Thema
Adjuvant therapy
7
Breast cancer
7
Journal Article
6
Adjuvant treatment intensity customization
4
Chemotherapy
4
Early breast cancer
4
Escalation and de-escalation
4
Immunogenicity
4
Immunotherapy
4
Luminal subtype
4
Neoadjuvant therapy
4
Safety
4
Special histology
4
Triple-negative breast cancer
4
Tumor-infiltrating lymphocytes
4
WHO classification
4
WT1 antigen
4
Biosimilar antibody
3
CT-P6
3
Extrapolation
3
Herceptin
3
Ki-67
3
Primary breast cancer
3
Prognosis
3
Trastuzumab
3
Triple-negative
3
EC 2.7.10.1
2
ERBB2 protein, human
2
Receptor, ErbB-2
2
Receptors, Progesterone
2
Research Support, Non-U.S. Gov't
2
Review
2
103107-01-3
1
Antibodies
1
Antibodies, Monoclonal
1
Antigens, Neoplasm
1
Biomarkers, Tumor
1
Biosimilar Pharmaceuticals
1
Cancer Vaccines
1
Clinical Trial, Phase I
1
Clinical Trial, Phase II
1
Cytokines
1
ESR1 protein, human
1
Estrogen Receptor alpha
1
Fibroblast Growth Factor 2
1
Ki-67 Antigen
1
Multicenter Study
1
Randomized Controlled Trial
1
Receptors, Estrogen
1
Recombinant Proteins
1
mehr ...